Search

Your search keyword '"Ma, D.J"' showing total 221 results

Search Constraints

Start Over You searched for: Author "Ma, D.J" Remove constraint Author: "Ma, D.J"
221 results on '"Ma, D.J"'

Search Results

1. 30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675)

2. Patient-specific 3D CT Images Reconstruction from 2D KV Images

3. Characteristics and Survival of Patients with Primary and Secondary Distant Metastasis of Oropharyngeal Squamous Cell Carcinoma (OPSCC)

5. Comparison of Induction Cisplatin, Docetaxel, and 5-Fluorouracil to An Induction Platinum Doublet Regimen for Locally Advanced Human Papillomavirus-Associated Oropharyngeal Cancer

6. Sensitivity of the PROMIS-10 for Capturing Radiation-Related Quality of Life Changes

7. Unique T-cell Sub-Population Shifts after SBPT and Nivolumab in Platinum Refractory HNC: Biomarker Correlates from ROR1771

8. ctHPVDNA and Recurrence Risk in MC1675, a Secondary Analysis of a Phase III Evaluation of De-Escalated Adjuvant Radiation Therapy (DART) vs. Standard Adjuvant Treatment for HPV Associated Oropharyngeal Squamous Cell Carcinoma

9. A Prospective Observational Study of Proton Stereotactic Body Radiation Therapy and Immunotherapy for Recurrent Metastatic Head and Neck Cancer: Initial Report of MC ROR1771 Survival Analysis and Toxicity

10. Correlation and Prediction of Modified Barium Swallowing Study with Patient-Reported Outcomes (PROs) for HPV Associated Oropharyngeal Squamous Cell Carcinoma

11. Comparisons of Patient-Reported Quality of Life and Swallowing Scores of Mucosal Sparing Radiation vs. Standard of Care for Oropharyngeal Tumors

12. Reliability of Cancer Recurrence Data: Institution Cancer Registry vs. Trained Chart Abstraction

13. Patient Reported Outcomes (PROs) in MC1675, De-Escalated Adjuvant Radiation Therapy (DART) vs. Standard of Care Adjuvant Radiation Therapy (SOC) for HPV Associated Oropharyngeal Squamous Cell Carcinoma

14. Adenoid Cystic Carcinoma of the Head and Neck: Patterns of Recurrence and Implications for Radiotherapy

15. Spatially Fractionated Radiation Therapy in the Modern Era: The Mayo Clinic Experience

22. 30-Day Morbidity and Bleeding Rates Associated with Transoral Robotic Surgery for HPV Associated Oropharyngeal Squamous Cell Carcinoma: A Retrospective Analysis of Two Prospective Adjuvant Radiotherapy Deescalation Trials (MC1273 & MC1675)

23. Non-Inferiority Margin and Nodal Analysis of De-Escalated Adjuvant Radiation Therapy (DART) for HPV-Related Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Preplanned Pooled Analysis of MC1273 & MC1675

24. Speech and Swallowing Function Following De-Escalation Adjuvant Chemoradiotherapy or Standard of Care Adjuvant Therapy for HPV Associated Oropharyngeal Carcinoma: A Prospective Randomized Trial

25. The Number of Radiographically Positive Lymph Nodes is Predictive of Survival in HPV-Associated Oropharyngeal Cancer and Further Stratifies Outcomes Beyond Clinical Staging Alone

26. Analysis of Outcomes by Smoking Status in a Phase III Trial of De-Escalated Adjuvant Chemoradiation Therapy in Human Papillomavirus (HPV(+)) Oropharyngeal Squamous Cell Carcinoma (OPSCC)

27. A Prospective Study of Mucosal Sparing Proton Beam Therapy in Resected Oropharyngeal Cancer Patients

28. Hippocampal Sparing Radiotherapy in adults with Primary Brain Tumors: A comparative planning and dosimetric study using IMPT, IMRT and 3DCRT

33. Long-Term Results for MC1273, A Phase II Evaluation of De-Escalated Adjuvant Radiation Therapy for Human Papillomavirus Associated Oropharyngeal Squamous Cell Carcinoma (HPV+ OPSCC)

35. Anaplastic Thyroid Cancer Patterns of Nodal Disease and Proposed Radiotherapy Target Volumes

36. Clinical Outcomes of Histologically Verified Salivary Ductal Carcinomas: Retrospective Analysis of 89 Patients Treated Over 47 Years

37. Comparison of Clinical and Toxicity Outcomes of Adenoid Cystic Carcinomas Treated With Intensity Modulated Radiation Therapy vs. Proton Radiotherapy

38. Oncologic Outcomes for Skin Malignancies of the Head and Neck Treated with Protons, Photons or Electrons

40. Pre-Treatment Circulating Tumor Human Papillomavirus (HPV) DNA and Recurrence Risk in HPV Associated Malignancy: Oropharyngeal, Anal Canal, and Cervical Cancer

41. A Prospective Study of Mucosal Sparing Proton Beam Therapy in Resected Oropharyngeal Cancer Patients: Toxicity, Quality of Life and Swallow Function

42. Quantity of ctDNA by Risk Category for Post-Operative Patients with HPV Associated Oropharyngeal Squamous Cell Carcinoma

43. Risk Factors for Disease Progression Following Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus–Associated Oropharynx Squamous Cell Carcinoma (HPV-OSCC)

44. Genetic and micro-environmental factors influencing response to definitive 30Gy chemo-radiotherapy (chemoRT) in HPV Positive Oropharyngeal Cancer (OPC)

46. Detectable HPV ctDNA in Post-Operative Oropharyngeal Squamous Cell Carcinoma Patients is Associated With Progression

49. Comparison of Patient-Reported Outcomes and Acute Toxicities in Oropharyngeal Cancer Patients Treated with VMAT Vs IMPT

Catalog

Books, media, physical & digital resources